A detailed history of Group One Trading, L.P. transactions in Kamada LTD stock. As of the latest transaction made, Group One Trading, L.P. holds 668 shares of KMDA stock, worth $3,887. This represents 0.0% of its overall portfolio holdings.

Number of Shares
668
Previous 800 16.5%
Holding current value
$3,887
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.83 - $6.25 $637 - $825
-132 Reduced 16.5%
668 $3,000
Q4 2023

Feb 14, 2024

BUY
$4.14 - $6.22 $3,311 - $4,976
800 New
800 $4,000
Q2 2022

Aug 11, 2022

SELL
$4.22 - $5.85 $29,118 - $40,365
-6,900 Reduced 62.36%
4,164 $19,000
Q1 2022

May 12, 2022

SELL
$5.43 - $6.81 $240,923 - $302,152
-44,369 Reduced 80.04%
11,064 $61,000
Q3 2021

Nov 12, 2021

BUY
$5.25 - $5.87 $141,004 - $157,656
26,858 Added 93.99%
55,433 $294,000
Q2 2021

Aug 10, 2021

BUY
$5.67 - $6.33 $162,020 - $180,879
28,575 New
28,575 $166,000

Others Institutions Holding KMDA

About KAMADA LTD


  • Ticker KMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 44,800,500
  • Market Cap $261M
  • Description
  • Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...
More about KMDA
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.